Trial registration and declaration of registration by authors of randomized controlled trials

Transplantation

Volumn 92, Issue 10, 2011, Pages 1094-1100

  McGee, Richard G ^a,b   Su, Michael ^b   Kelly, Patrick J ^b   Higgins, Gail Y ^a   Craig, Jonathan C ^a,b   Webster, Angela C ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Cohort study; Kidney transplantation; Registration declaration; Trial registration

Indexed keywords

ARTICLE; COHORT ANALYSIS; FUNDING; KIDNEY TRANSPLANTATION; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTRATION; REGISTRATION DECLARATION; TRIAL REGISTRATION;

COHORT STUDIES; HUMANS; KIDNEY TRANSPLANTATION; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80855139557     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318232baf2     Document Type: Article

References (31)

1. Rennie D. Trial registration: A great idea switches from ignored to irresistible. JAMA 2004; 292: 1359.
2. Ghersi D, Pang T. En route to international clinical trial transparency. Lancet 2008; 372: 1531.
3. Simes RJ. Publication bias: The case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1529.
4. Ross JS, Mulvey GK, Hines EM, et al. Trial publication after registration in ClinicalTrials.Gov: A cross-sectional analysis. PLoS Med 2009; 6: e1000144.
5. Cowley A, Skene A, Stainer K, et al. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: An example of publication bias. Int J Cardiol 1993; 40: 161.
6. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 2004; 363: 1341.
7. Dickersin K, Chan S, Chalmers TC, et al. Publication bias and clinical trials. Control Clin Trials 1987; 8: 343.
8. De Angelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Med J Aust 2004; 181: 293.
9. Evans T, Gulmezoglu M, Pang T. Registering clinical trials: An essential role for WHO. Lancet 2004; 363: 1413.
10. Krleža-Jeric K, Lemmens T. 7th revision of the Declaration of Helsinki: Good news for the transparency of clinical trials. Croat Med J 2009; 50: 105.
11. Krleža-Jeric K, Chan AW, Dickersin K, et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 2005; 330: 956.
12. World Association of Medical Editors. The registration of clinical trials. Available at: http://www.wame.org/resources/policies#trialreg. Accessed January 1, 2011.
13. The Surgery Journal Editors Group. Consensus statement on mandatory registration of clinical trials. Ann Surg 2007; 245: 505.
14. International Clinical Trials Registry Platform (ICTRP). About registries. Available at: http://www.who.int/ictrp/network/trds/en/index.html. Accessed January 1, 2011.
15. Mathieu S, Boutron I, Moher D, et al. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009; 302: 977.
16. Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 2009; 10: 116.
17. Reveiz L, Cortés-Jofré M, Asenjo Lobos C, et al. Influence of trial registration on reporting quality of randomized trials: Study from highest ranked journals. J Clin Epidemiol 2010; 11: 1216.
18. Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 2003; 290: 921.
19. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170: 477.
20. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003; 326: 1167.
21. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002; 359: 248.
22. Moja L. Clinical trials: Trial registration cannot alone transform scientific conduct. Nat Rev Urol 2010; 7: 7.
23. Dahm M, González P, Porteiro N. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. J Health Econ 2009; 28: 1141.
24. Smyth RM, Kirkham JJ, Jacoby A, et al. Frequency and reasons for outcome reporting bias in clinical trials: Interviews with trialists. BMJ 2011; 342: c7153.
25. Chan AW. Access to clinical trial data. BMJ 2011; 342: d80.
26. Godlee F. Goodbye PubMed, hello raw data. BMJ 2011; 342: d212.
27. Chan AW, Tetzlaff J, Altman DG, et al. The SPIRIT initiative: Defining standard protocol items for randomized trials. German J Evid Quality Health Care (suppl) 2008; 102: s27.
28. Graf C, Battisti W, Bridges D, et al. Good publication practice for communicating company sponsored medical research: The GPP2 guidelines. BMJ 2009; 339: b4330.
29. Henderson LK, Craig JC, Willis NS, et al. How to write a Cochrane systematic review. Nephrology (Carlton) 2010; 15: 617.
30. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata [ed. 2], College Station, TX: Stata Press 2008.
31. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings:Anupdated review of related biases. Health Technol Assess 2010; 14: 1.